Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
Epidemiology, definition and treatment of complicated urinary tract infections
FME Wagenlehner, TE Bjerklund Johansen… - Nature Reviews …, 2020 - nature.com
UTIs are amongst the most frequent bacterial infections. However, the clinical phenotypes of
UTI are heterogeneous and range from rather benign, uncomplicated infections to …
UTI are heterogeneous and range from rather benign, uncomplicated infections to …
Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem …
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …
Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae
J Rodríguez-Baño, B Gutiérrez-Gutiérrez… - Clinical microbiology …, 2018 - Am Soc Microbiol
Therapy of invasive infections due to multidrug-resistant Enterobacteriaceae (MDR-E) is
challenging, and some of the few active drugs are not available in many countries. For …
challenging, and some of the few active drugs are not available in many countries. For …
[HTML][HTML] European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram …
Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …
Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents
MS Bader, M Loeb, D Leto, AA Brooks - Postgraduate medicine, 2020 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited treatment options. Knowledge of the common uropathogens …
growing concern due to limited treatment options. Knowledge of the common uropathogens …
[HTML][HTML] Carbapenem-sparing strategies for ESBL producers: when and how
I Karaiskos, H Giamarellou - Antibiotics, 2020 - mdpi.com
Extended spectrum β-lactamase (ESBL)-producing bacteria are prevalent worldwide and
correlated with hospital infections, but they have been evolving as an increasing cause of …
correlated with hospital infections, but they have been evolving as an increasing cause of …
[HTML][HTML] Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?
ZD Pana, T Zaoutis - F1000Research, 2018 - ncbi.nlm.nih.gov
The spread of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae
(ESBL-PE) has dramatically increased worldwide, and this “evolving crisis” is currently …
(ESBL-PE) has dramatically increased worldwide, and this “evolving crisis” is currently …
Is piperacillin-tazobactam effective for the treatment of pyelonephritis caused by extended-spectrum β-lactamase–producing organisms?
Background Limited data exist regarding the efficacy of piperacillin-tazobactam (TZP) for the
management of nonbacteremic pyelonephritis caused by extended-spectrum β-lactamase …
management of nonbacteremic pyelonephritis caused by extended-spectrum β-lactamase …
[HTML][HTML] Guidelines for antibiotic prescription in intensive care unit
GC Khilnani, K Zirpe, V Hadda, Y Mehta… - Indian journal of …, 2019 - ncbi.nlm.nih.gov
How to cite this article: Khilnani GC, Zirpe K, Hadda V, Mehta Y, Madan K, Kulkarni A,
Mohan A, Dixit S, Guleria R, Bhattacharya P. Guidelines for Antibiotic Prescription in …
Mohan A, Dixit S, Guleria R, Bhattacharya P. Guidelines for Antibiotic Prescription in …